Genetics researcher and senior vice president of the pharmaceutical giant, David Cox, has passed away unexpectedly at age 66.
Advertisement
The Scientist
Most Recent
Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.
The majority of human melanomas contain mutations in a gene promoter, suggesting mutations in regulatory regions may spur some cancers.
After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
As wolves became domesticated, their genes adapted to a starch-rich diet of human leftovers.
Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
Scientists provide evidence for the existence of four-stranded human DNA, which has previously only been theorized and synthesized.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
The release of infectious agents from the lab is not uncommon, but lab-acquired infections are rare.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
